Answers are grounded in this paper and cite their sources.
Case report demonstrates fatal disease progression in a patient with refractory pyoderma gangrenosum, highlighting the critical need for prompt diagnosis and effective systemic therapies.
Ulcerative pyoderma gangrenosum (PG) is characterized by proliferative, necrotic, deep, and undermined ulcers that occur either singly or as multiple lesions on the lower extremities of the body.We report the case of a 68-year-old man who was initially treated for a diabetic ulcer.However, based on the characteristic clinical features, including pathergy, severe pain, and edematous erythema surrounding the ulcers, a diagnosis of PG was established.Systemic corticosteroids were not administered because of patientspecific factors.Alternative systemic therapies, including adalimumab, granulocyte and monocyte adsorption apheresis, and cyclosporine, were sequentially initiated.However, disease control was not achieved, and his condition progressively worsened, thus resulting in death 14 months after the initial presentation and approximately 26 months after the disease onset.PG demonstrates a broad spectrum of severity, ranging from mild, self-limiting disease to severe, potentially fatal presentations.Because diagnostic uncertainty often delays treatment initiation, the early recognition of PG and prompt initiation of appropriate systemic therapy are critical, particularly in cases of progressive and refractory ulcers.
No takes yet. Share an insight, caveat, or question.
Shoji et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: